I think that there's potential for a thriving black market for HCV drugs, thanks to proprietary, exclusionary business[as usual] practices.

That is an excellent article.  Thanks, Angel.

This makes for interesting reading about how and why Gilead operate the way they do.

http://www.hepcoalition.org/news/article/gilead-s-license-on-hepatitis-c